US Stock MarketDetailed Quotes

SAGE Sage Therapeutics

Watchlist
  • 5.170
  • +0.320+6.60%
Close Nov 22 16:00 ET
316.27MMarket Cap-928P/E (TTM)

Sage Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Sage Therapeutics Q3 2024 Earnings Date

Currency：USDOct 29, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
10.85M
11.87M
+1.02M
Beat Est.
+299.62%
+337.08%
+9.37%
EPS
-1.54
-1.53
+<0.01
Beat Est.
+54.38%
+54.60%
+0.47%
Analyst Rating
Hold

Nov 24, 2024

Sage Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 6 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 16.523M--
--2024/Q4-- / 14.160M--
Oct 29, 20242024/Q311.871M / 10.854M--
Jul 31, 20242024/Q28.654M / 8.867M--
Apr 25, 20242024/Q17.902M / 5.187M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 16.523M--
--2024/Q4-- / 14.160M--
Oct 29, 20242024/Q311.871M / 10.854M--
Jul 31, 20242024/Q28.654M / 8.867M--
Apr 25, 20242024/Q17.902M / 5.187M--

Unlock Free Earnings Estimates

Sage Therapeutics Earnings Reports

  • Sage Therapeutics | 10-Q: Q3 2024 Earnings Report

    Oct 29 16:24 ET

  • Sage Therapeutics | 8-K: Sage Therapeutics Announces Third Quarter 2024 Financial Results and Highlights Pipeline and Business Updates

    Oct 29 16:14 ET

  • Sage Therapeutics | 10-Q: Q2 2024 Earnings Report

    Jul 31 16:19 ET

  • Sage Therapeutics | 8-K: Sage Therapeutics Announces Second Quarter 2024 Financial Results and Highlights Pipeline and Business Progress

    Jul 31 16:14 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 24, 2024

    Hold

    • Buy

      12.50%

    • Hold

      75.00%

    • Sell

      12.50%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data